# Commission Implementing Decision of 27 June 2012 concerning a financial contribution by the Union to Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom for studies on Schmallenberg virus (notified under document C(2012) 4203) (Only the Dutch, English, French, German, Italian and Spanish texts are authentic) (2012/349/EU), Division: Project 1.3

Extent: E+W+S+N.I.

To study the development of immunity to SBV by experimental infection studies in sero-positive as well as sero-negative animals of the different species.
Member States involved: Belgium, Germany, France, the Netherlands and the United Kingdom.
Coordinator: United Kingdom
Outcome for projects 1.1, 1.2 and 1.3:
Data on pathogenesis, viremia duration, incubation time, virus distribution, virus shedding and possible persistence of Schmallenberg virus to be used for tests on live animals, generation of vaccines as well as collection of reference materials for tests’ validation.

---
Source: https://www.legislation.gov.uk/eudn/2012/349/annex/I/division/Area/division/3 (the official version)
Page: https://openlegislation.uk/eu-decision-2012-349/annex-I/division-Area/division-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.